Stay updated on Remibrutinib Long-term Extension in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remibrutinib Long-term Extension in Urticaria Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record now presents details for a remibrutinib extension study in chronic spontaneous urticaria, including its study design, eligibility criteria, outcomes, and locations. It also includes the study’s current status and participant data-sharing information.
    Difference
    100%
    Check dated 2026-11-09T13:59:40.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the study record page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:11:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T14:40:39.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:16:44.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:44:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a generic error screen. This blocks access to the trial details that were previously visible on the page.
    Difference
    17%
    Check dated 2026-09-21T22:12:31.000Z thumbnail image

Stay in the know with updates to Remibrutinib Long-term Extension in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.